Overview

Gina Ogilvie, MD MSc FCFP DrPH is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre.

Dr. Ogilvie is currently principal investigator on over $13-million in research grants and she has received funding from PHAC, CIHR, Michael Smith Foundation for Health Research, Canadian Foundation for Innovation and private foundations including BC Women’s Hospital Foundation among others.

Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally.

She has published over 100 peer reviewed manuscripts and has provided advice and consultation to national and global institutions, including the Canadian Partnership Against Cancer, Public Health Agency of Canada, the World Health Organization and Ministries of Health globally on STI, HIV and HPV vaccine policy and programming.

She speaks widely at international and national research and education conferences, and has supervised medical students, residents, and graduate students throughout her career.

Publications

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S
DOI: 10.1016/j.ypmed.2016.11.029
PubMed: 28279264
05/2017

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S
DOI: 10.1016/j.ypmed.2016.11.030
PubMed: 28279257
05/2017

Improving linkage to HIV care at low-threshold STI/HIV testing sites: An evaluation of the Immediate Staging Pilot Project in Vancouver, British Columbia.
Brownrigg B, Taylor D, Phan F, Sandstra I, Stimpson R, Barrios R, Lester R, Ogilvie G
DOI: 10.17269/cjph.108.5753
PubMed: 28425903
04/2017

Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting.
Patterson S, Kaida A, Ogilvie G, Hogg R, Nicholson V, Dobrer S, Kerr T, Shoveller J, Montaner J, Milloy MJ
DOI: 10.1016/j.drugpo.2017.02.003
PubMed: 28363120
03/2017

Use of GetCheckedOnline, a Comprehensive Web-based Testing Service for Sexually Transmitted and Blood-Borne Infections.
Gilbert M, Salway T, Haag D, Fairley CK, Wong J, Grennan T, Uddin Z, Buchner CS, Wong T, Krajden M, Tyndall M, Shoveller J, Ogilvie G
DOI: 10.2196/jmir.7097
PubMed: 28320690
03/2017

Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS
DOI: 10.1002/ijc.30695
PubMed: 28297074
03/2017

On the duration of the period between exposure to HIV and detectable infection.
Konrad BP, Taylor D, Conway JM, Ogilvie GS, Coombs D
DOI: 10.1016/j.epidem.2017.03.002
PubMed: 28365331
03/2017

Evidence that supports policies to delay cervical screening until after age 25 years.
Dickinson JA, Ogilvie G, Van Niekerk D, Popadiuk C
DOI: 10.1503/cmaj.160636
PubMed: 28385818
03/2017

Sustained Reduction in Sexual Behavior that May Pose a Risk of HIV Transmission Following Diagnosis During Early HIV Infection Among Gay Men in Vancouver, British Columbia.
Gilbert M, Taylor D, Michelow W, Grace D, Balshaw R, Kwag M, Lim E, Fischer B, Patrick D, Ogilvie G, Coombs D, Steinberg M, Rekart M
DOI: 10.1007/s10461-017-1702-0
PubMed: 28168375
02/2017

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
Cook DA, Smith LW, Law J, Mei W, van Niekerk DJ, Ceballos K, Gondara L, Franco EL, Coldman AJ, Ogilvie GS, Jang D, Chernesky M, Krajden M
DOI: 10.1016/j.jcv.2016.12.004
PubMed: 27988420
02/2017

Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, Biryabarema C, Christilaw J, Byamugisha JK, Money DM, Ogilvie GS
DOI: 10.1186/s12905-016-0360-0
PubMed: 28086933
01/2017

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook D, Ceballos K, Lee M, Gentile L, Gondara L, Elwood-Martin R, Peacock S, Stuart G, Franco EL, Coldman AJ
DOI: 10.1002/ijc.30454
PubMed: 27685757
01/2017

Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study.
Perez S, Tatar O, Shapiro GK, Dubé E, Ogilvie G, Guichon J, Gilca V, Rosberger Z
DOI: 10.1186/s12889-016-3828-9
PubMed: 27919239
12/2016

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.
Coldman AJ, Gondara L, Smith LW, van Niekerk D, Ceballos K, Krajden M, Cook D, Quinlan DJ, Lee M, Stuart GC, Peacock S, Martin RE, Gentile L, Franco EL, Ogilvie GS
DOI: 10.1038/bjc.2016.368
PubMed: 27855441
12/2016

Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A, van Niekerk D, Smith L, Ogilvie G
PubMed: 27810984
11/2016

Get Checked… Where? The Development of a Comprehensive, Integrated Internet-Based Testing Program for Sexually Transmitted and Blood-Borne Infections in British Columbia, Canada.
Gilbert M, Haag D, Hottes TS, Bondyra M, Elliot E, Chabot C, Farrell J, Bonnell A, Kopp S, Andruschak J, Shoveller J, Ogilvie G
DOI: 10.2196/resprot.6293
PubMed: 27649716
09/2016

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
Money DM, Moses E, Blitz S, Vandriel SM, Lipsky N, Walmsley SL, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein M, Harris M, Cohen J, Wobeser W, Bitnun A, Lapointe N, Samson L, Brophy J, Karatzios C, Ogilvie G
DOI: 10.1016/j.vaccine.2016.08.016
PubMed: 27544584
09/2016

Biomedical technologies for the prevention of sexually transmitted infections and HIV for adolescent girls and young women.
Narasimhan M, Vermund SH, Ogilvie G
PubMed: 27794092
09/2016

Trends in Syphilis Partner Notification Among Gay, Bisexual, and Other Men who Have Sex With Men in British Columbia, 2010 to 2013.
Deonarine A, Ogilvie G, Montgomery C, Makaroff S, Holgerson N, Grennan T, Gilbert M, Wong J
DOI: 10.1097/olq.0000000000000494
PubMed: 27414679
08/2016

Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial.
Smith L, van Niekerk D, Coldman A, Krajden M, Franco EL, Ogilvie G
DOI: 10.1016/j.jogc.2016.04.009
PubMed: 27638983
08/2016

Factors Associated with Productive Recruiting in a Respondent-Driven Sample of Men who Have Sex with Men in Vancouver, Canada.
Forrest JI, Lachowsky NJ, Lal A, Cui Z, Sereda P, Raymond HF, Ogilvie G, Roth EA, Moore D, Hogg RS
DOI: 10.1007/s11524-016-0032-2
PubMed: 26960428
04/2016

Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS, Smith LW, van Niekerk D, Khurshed F, Pedersen HN, Taylor D, Thomson K, Greene SB, Babich SM, Franco EL, Coldman AJ
DOI: 10.1186/s12889-016-2865-8
PubMed: 26935960
03/2016

Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
Salters KA, Cescon A, Zhang W, Ogilvie G, Murray MC, Coldman A, Hamm J, Chiu CG, Montaner JS, Wiseman SM, Money D, Pick N, Hogg RS
DOI: 10.1111/hiv.12290
PubMed: 26268461
03/2016

Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y, Rangiah C, Gorelik A, Ogilvie G, Wark JD, Hartley S, Garland SM
DOI: 10.1016/j.jcv.2015.10.026
PubMed: 26589584
03/2016

Clinicians' attitude towards changes in Australian National Cervical Screening Program.
Yap D, Liang X, Garland SM, Hartley S, Gorelik A, Ogilvie G, Tan J, Wrede CD, Jayasinghe Y
DOI: 10.1016/j.jcv.2015.11.018
PubMed: 26651602
03/2016

Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.
Cromwell I, Ferreira Z, Smith L, van der Hoek K, Ogilvie G, Coldman A, Peacock SJ
DOI: 10.3747/co.23.2914
PubMed: 26985142
02/2016

Barriers to Cervical Screening Among Sex Workers in Vancouver.
Duff P, Ogilvie G, Shoveller J, Amram O, Chettiar J, Nguyen P, Dobrer S, Montaner J, Shannon K
DOI: 10.2105/ajph.2015.302863
PubMed: 26562102
02/2016

Strategies for Increasing Cervical Cancer Screening Amongst First Nations Communities in Northwest Ontario, Canada.
Maar M, Wakewich P, Wood B, Severini A, Little J, Burchell AN, Ogilvie G, Zehbe I
DOI: 10.1080/07399332.2014.959168
PubMed: 25375661
2016

Strategies for Community Education Prior to Clinical Trial Recruitment for a Cervical Cancer Screening Intervention in Uganda.
Mitchell SM, Pedersen HN, Sekikubo M, Biryabarema C, Byamugisha JJ, Mwesigwa D, Steinberg M, Money DM, Ogilvie GS
DOI: 10.3389/fonc.2016.00090
PubMed: 27148482
2016

Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.
Patterson S, Kaida A, Nguyen P, Dobrer S, Ogilvie G, Hogg R, Kerr T, Montaner J, Wood E, Milloy MJ
DOI: 10.9778/cmajo.20150106
PubMed: 27398360
2016

Establishing the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study.
Loutfy M, Greene S, Kennedy VL, Lewis J, Thomas-Pavanel J, Conway T, de Pokomandy A, O'Brien N, Carter A, Tharao W, Nicholson V, Beaver K, Dubuc D, Gahagan J, Proulx-Boucher K, Hogg RS, Kaida A, CHIWOS Research Team
DOI: 10.1186/s12874-016-0190-7
PubMed: 27543135
2016

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
Cook DA, Mei W, Smith LW, van Niekerk DJ, Ceballos K, Franco EL, Coldman AJ, Ogilvie GS, Krajden M
DOI: 10.1186/s12885-015-1959-5
PubMed: 26674353
12/2015

Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.
Ogilvie GS, Naus M, Money DM, Dobson SR, Miller D, Krajden M, van Niekerk DJ, Coldman AJ
DOI: 10.1002/ijc.29508
PubMed: 25754686
10/2015

Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, Biryabarema C, Byamugisha JK, Money DM, Ogilvie GS
DOI: 10.1111/tmi.12549
PubMed: 26031572
10/2015

Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines.
Falasinnu T, Gilbert M, Hottes TS, Gustafson P, Ogilvie G, Shoveller J
DOI: 10.1177/0956462414555930
PubMed: 25324350
10/2015

Health care providers' perspectives on a weekly text-messaging intervention to engage HIV-positive persons in care (WelTel BC1).
Murray MC, O'Shaughnessy S, Smillie K, Van Borek N, Graham R, Maan EJ, van der Kop ML, Friesen K, Albert A, Levine S, Pick N, Ogilvie G, Money D, Lester R, WelTel BC1 Study Team
DOI: 10.1007/s10461-015-1151-6
PubMed: 26297567
10/2015

Current status of human papillomavirus vaccination.
Brotherton JM, Ogilvie GS
DOI: 10.1097/cco.0000000000000211
PubMed: 26258273
09/2015

'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons.
Perez S, Shapiro GK, Brown CA, Dube E, Ogilvie G, Rosberger Z
PubMed: 26152776
07/2015

The relationship between social, policy and physical venue features and social cohesion on condom use for pregnancy prevention among sex workers: a safer indoor work environment scale.
Duff P, Shoveller J, Dobrer S, Ogilvie G, Montaner J, Chettiar J, Shannon K
DOI: 10.1136/jech-2014-204427
PubMed: 25678713
07/2015

Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE, Gratrix J, Martin I, Friedman DS, Hoang L, Lester R, Metz G, Ogilvie G, Read R, Wong T
DOI: 10.1097/olq.0000000000000280
PubMed: 25970311
06/2015

Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
Coldman AJ, Phillips N, van Niekerk D, Smith L, Krajden M, Cook D, Quinlan DJ, Ehlen T, Miller D, Stuart GC, Peacock S, Martin RE, Franco EL, Ogilvie G
DOI: 10.1016/s1701-2163(15)30255-3
PubMed: 26168101
05/2015

Pregnancy intentions among female sex workers: recognising their rights and wants as mothers.
Duff P, Shoveller J, Feng C, Ogilvie G, Montaner J, Shannon K
DOI: 10.1136/jfprhc-2012-100532
PubMed: 25056256
04/2015

Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.
Ling DI, Janjua NZ, Wong S, Krajden M, Hoang L, Morshed M, Achen M, Murti M, Lester RT, Wong J, Ogilvie G, Gilbert M
DOI: 10.1097/olq.0000000000000250
PubMed: 25668648
03/2015

Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling.
Taylor D, Durigon M, Davis H, Archibald C, Konrad B, Coombs D, Gilbert M, Cook D, Krajden M, Wong T, Ogilvie G
DOI: 10.1177/0956462414542987
PubMed: 25033879
03/2015

The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence.
Patterson SE, Milloy MJ, Ogilvie G, Greene S, Nicholson V, Vonn M, Hogg R, Kaida A
DOI: 10.7448/ias.18.1.20572
PubMed: 26701080
2015

Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance.
Kaida A, Carter A, de Pokomandy A, Patterson S, Proulx-Boucher K, Nohpal A, Sereda P, Colley G, O'Brien N, Thomas-Pavanel J, Beaver K, Nicholson VJ, Tharao W, Fernet M, Otis J, Hogg RS, Loutfy M, CHIWOS Research Team
DOI: 10.7448/ias.18.6.20284
PubMed: 26643457
2015

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis.
Lunny C, Taylor D, Hoang L, Wong T, Gilbert M, Lester R, Krajden M, Ogilvie G
DOI: 10.1371/journal.pone.0132776
PubMed: 26168051
2015

Test uptake and case detection of syphilis, HIV, and hepatitis C among women undergoing prenatal screening in British Columbia, 2007 to 2011.
Kuo M, Money DM, Alvarez M, Buxton JA, Krajden M, Lester RT, Ogilvie G, Gilbert M
DOI: 10.1016/s1701-2163(15)30561-2
PubMed: 24927185
06/2014

A critical appraisal of risk models for predicting sexually transmitted infections.
Falasinnu T, Gustafson P, Hottes TS, Gilbert M, Ogilvie G, Shoveller J
DOI: 10.1097/olq.0000000000000120
PubMed: 24722388
05/2014

Short message service (SMS) interventions for the prevention and treatment of sexually transmitted infections: a systematic review protocol.
Lunny C, Taylor D, Memetovic J, Wärje O, Lester R, Wong T, Ho K, Gilbert M, Ogilvie G
DOI: 10.1186/2046-4053-3-7
PubMed: 24433348
01/2014

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.
Krajden M, Cook D, Yu A, Chow R, Su Q, Mei W, McNeil S, Money D, Dionne M, Palefsky J, Karunakaran K, Kollmann T, Ogilvie G, Petric M, Dobson S
DOI: 10.1016/j.vaccine.2013.09.007
PubMed: 24055350
01/2014

Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa.
Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JJ, Steinberg M, Jeronimo J, Money DM, Christilaw J, Ogilvie GS
DOI: 10.1016/j.ajog.2013.08.038
PubMed: 23999419
01/2014

Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW, Khurshed F, van Niekerk DJ, Krajden M, Greene SB, Hobbs S, Coldman AJ, Franco EL, Ogilvie GS
DOI: 10.1186/1471-2458-14-1060
PubMed: 25303975
2014

Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
Teng FF, Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JK, Steinberg M, Money DM, Ogilvie GS
DOI: 10.1136/bmjopen-2014-004783
PubMed: 24727360
2014

Using community engagement to inform and implement a community-randomized controlled trial in the anishinaabek cervical cancer screening study.
Wood B, Burchell AN, Escott N, Little J, Maar M, Ogilvie G, Severini A, Bishop L, Morrisseau K, Zehbe I
DOI: 10.3389/fonc.2014.00027
PubMed: 24600584
2014

Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006-2011.
Gilbert M, Hottes TS, Lester R, Gustafson R, Krajden M, Ogilvie G
PubMed: 24735699
2014

Factors associated with intention to use internet-based testing for sexually transmitted infections among men who have sex with men.
Gilbert M, Hottes TS, Kerr T, Taylor D, Fairley CK, Lester R, Wong T, Trussler T, Marchand R, Shoveller J, Ogilvie G
DOI: 10.2196/jmir.2888
PubMed: 24240644
11/2013

Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol.
Taylor D, Lunny C, Wong T, Gilbert M, Li N, Lester R, Krajden M, Hoang L, Ogilvie G
DOI: 10.1186/2046-4053-2-93
PubMed: 24112441
10/2013

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC
DOI: 10.1016/j.vaccine.2013.06.064
PubMed: 23830974
08/2013

Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda.
Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, Miller D, Steinberg M, Money DM
DOI: 10.1016/j.ijgo.2013.03.019
PubMed: 23731506
08/2013

Exploring colposcopists' attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia.
Regier DA, van der Hoek K, Ogilvie G, Smith L, Henwood E, Miller DM, McTaggart-Cowan H, Peacock SJ
PubMed: 23876645
07/2013

Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis.
Rossi G, Bertani C, Mari S, Marini C, Renzoni G, Ogilvie G, Magi GE
DOI: 10.1007/s11259-013-9550-5
PubMed: 23315207
06/2013

High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ
DOI: 10.1002/ijc.27790
PubMed: 22907569
05/2013

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E
DOI: 10.1001/jama.2013.1625
PubMed: 23632723
05/2013

Community-based HIV and STI prevention in women working in indoor sex markets.
Bungay V, Kolar K, Thindal S, Remple VP, Johnston CL, Ogilvie G
DOI: 10.1177/1524839912447189
PubMed: 22885289
03/2013

Gonorrhea as a moving target: how do we sharpen our aim and strengthen our arrows?
Yudin MH, Salway Hottes T, Ogilvie GS
DOI: 10.1016/s1701-2163(15)31024-0
PubMed: 23470069
02/2013

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, Mei W, van Niekerk DJ, Coldman AJ, Krajden M
DOI: 10.1016/j.vaccine.2012.09.085
PubMed: 23273510
02/2013

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G
DOI: 10.1097/olq.0b013e31827bd64c
PubMed: 23250301
01/2013

Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
Gentschev I, Patil SS, Adelfinger M, Weibel S, Geissinger U, Frentzen A, Chen NG, Yu YA, Zhang Q, Ogilvie G, Szalay AA
DOI: 10.4161/bioe.22462
PubMed: 23093804
2013

A brief tool to assess capacity to consent for medical care among homeless individuals with problematic substance use: study protocol.
Taylor D, Masse L, Ho A, Rekart ML, Tyndall M, Henry B, Clifton J, Peters L, Ogilvie G, Buxton J
DOI: 10.1186/0778-7367-71-11
PubMed: 23651056
2013

A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women.
Maar M, Burchell A, Little J, Ogilvie G, Severini A, Yang JM, Zehbe I
DOI: 10.1016/j.whi.2013.06.005
PubMed: 23993479
2013

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K, Smith LW, Kan L, Cook DA, Peacock S, Stuart GC, Franco EL, Coldman AJ
DOI: 10.1038/bjc.2012.489
PubMed: 23169286
12/2012

Masculinities, 'guy talk' and 'manning up': a discourse analysis of how young men talk about sexual health.
Knight R, Shoveller JA, Oliffe JL, Gilbert M, Frank B, Ogilvie G
DOI: 10.1111/j.1467-9566.2012.01471.x
PubMed: 22471843
11/2012

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J
DOI: 10.1016/j.vaccine.2012.06.095
PubMed: 23199969
11/2012

Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
Steben M, Jeronimo J, Wittet S, Lamontagne DS, Ogilvie G, Jensen C, Smith J, Franceschi S
DOI: 10.1016/j.vaccine.2012.06.031
PubMed: 23199962
11/2012

Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs.
Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T, ManCount Study Team
DOI: 10.1016/j.vaccine.2012.07.001
PubMed: 22796376
08/2012

Rethinking cervical cancer screening.
Van Niekerk D, Ogilvie G, Miller D
PubMed: 22555131
05/2012

Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination.
Smolen KK, Gelinas L, Franzen L, Dobson S, Dawar M, Ogilvie G, Krajden M, Fortuno ES, Kollmann TR
DOI: 10.1016/j.vaccine.2012.03.051
PubMed: 22469863
05/2012

Management of group B streptococcal bacteriuria in pregnancy.
Allen VM, Yudin MH, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, Paquet C, van Schalkwyk J, Senikas V, Infectious Diseases Committee, Society of Obstetricians and Gynaecologists of Canada
PubMed: 22555143
05/2012

High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study.
Loutfy M, Raboud J, Wong J, Yudin M, Diong C, Blitz S, Margolese S, Hart T, Ogilvie G, Masinde K, Tharao W, Linklater G, Salam K, Ongoiba F, Angel J, Smaill F, Rachlis A, Ralph E, Walmsley S, Ontario HIV Fertility Research Team
DOI: 10.1111/j.1468-1293.2011.00946.x
PubMed: 22103297
02/2012

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
Patil SS, Gentschev I, Nolte I, Ogilvie G, Szalay AA
DOI: 10.1186/1479-5876-10-3
PubMed: 22216938
01/2012

Online sexual health services: examining youth's perspectives.
Shoveller J, Knight R, Davis W, Gilbert M, Ogilvie G
PubMed: 22338322
2012

Feasibility of incorporating self-collected rectal swabs into a community venue-based survey to measure the prevalence of HPV infection in men who have sex with men.
Gilbert M, Kwag M, Mei W, Rank C, Kropp R, Severini A, van Niekerk D, Zhou C, Press N, Ogilvie G, Wong T, ManCount Study Team
DOI: 10.1097/olq.0b013e318222899d
PubMed: 21934574
10/2011

Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda.
Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D
DOI: 10.1016/j.ijgo.2011.01.028
PubMed: 21669428
08/2011

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.
Krajden M, Cook D, Yu A, Chow R, Mei W, McNeil S, Money D, Dionne M, Karunakaran KP, Palefsky JM, Dobson S, Ogilvie G, Petric M
DOI: 10.1128/cvi.00489-10
PubMed: 21248158
03/2011

Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA
DOI: 10.1136/sti.2009.041392
PubMed: 20956352
02/2011

Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.
Gilbert M, Li X, Petric M, Krajden M, Isaac-Renton JL, Ogilvie G, Rekart ML
PubMed: 21714324
2011

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.
Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M
DOI: 10.1371/journal.pmed.1000270
PubMed: 20454567
05/2010

[Cytomegalovirus infection in pregnancy].
Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, Ouellet A, Pressey T, Roggensack A, Boucher M, Castillo E, Gruslin A, Money DM, Murphy K, Ogilvie G, Paquet C
PubMed: 20500944
04/2010

Cytomegalovirus infection in pregnancy.
Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, Ouellet A, Pressey T, Roggensack A, Boucher M, Castillo E, Gruslin A, Money DM, Murphy K, Ogilvie G, Paquet C
PubMed: 20500943
04/2010

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial).
Ogilvie GS, van Niekerk DJ, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook DA, Mei W, Stuart GC, Franco EL, Coldman AJ
DOI: 10.1186/1471-2407-10-111
PubMed: 20334685
03/2010

Primary health care: applying the principles within a community-based participatory health research project that began in a Canadian women's prison.
Martin RE, Murphy K, Chan R, Ramsden VR, Granger-Brown A, Macaulay AC, Kahlon R, Ogilvie G, Hislop TG
DOI: 10.1177/1757975909348114
PubMed: 20028668
12/2009

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia.
Krajden M, Karunakaran K, So S, Palefsky JM, Sharma R, Cook D, Yu A, Chow R, Dobson S, Ogilvie GS, Petric M
DOI: 10.1128/cvi.00238-09
PubMed: 19828766
12/2009

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.
Moore RA, Ogilvie G, Fornika D, Moravan V, Brisson M, Amirabbasi-Beik M, Kollar A, Burgess T, Hsu R, Towers L, Lo J, Matisic J, Brooks-Wilson A
DOI: 10.1007/s10552-009-9365-4
PubMed: 19475481
10/2009

Antibiotic therapy in preterm premature rupture of the membranes.
Yudin MH, van Schalkwyk J, Van Eyk N, Boucher M, Castillo E, Cormier B, Gruslin A, Money DM, Murphy K, Ogilvie G, Paquet C, Steenbeek A, Wong T, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Farine D, Grabowska K
PubMed: 19941711
09/2009

A population-based study of infectious syphilis rediagnosis in British Columbia, 1995-2005.
Ogilvie GS, Taylor DL, Moniruzzaman A, Knowles L, Jones H, Kim PH, Rekart ML
DOI: 10.1086/598997
PubMed: 19402790
06/2009

Self-collection of genital human papillomavirus specimens in heterosexual men.
Ogilvie GS, Taylor DL, Achen M, Cook D, Krajden M
DOI: 10.1136/sti.2008.033068
PubMed: 19066196
06/2009

Patients with genital warts have a decreased quality of life.
Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F
DOI: 10.1097/olq.0b013e318191a55e
PubMed: 19265737
04/2009

Epidemiology and costs associated with genital warts in Canada.
Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA
DOI: 10.1136/sti.2008.030999
PubMed: 18981170
04/2009

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.
Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G
DOI: 10.2165/00019053-200927020-00004
PubMed: 19254046
2009

Immunization in pregnancy.
Gruslin A, Steben M, Halperin S, Money DM, Yudin MH, Boucher M, Cormier B, Ogilvie G, Paquet C, Steenbeek A, Van Eyk N, van Schalkwyk J, Wong T
PubMed: 19175969
12/2008

Intention of parents to have male children vaccinated with the human papillomavirus vaccine.
Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak K, Ehlen T, Dobson S, Patrick DM, Money DM
DOI: 10.1136/sti.2007.029389
PubMed: 18445636
08/2008

Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?
Günther OP, Ogilvie G, Naus M, Young E, Patrick DM, Dobson S, Duval B, Noël PA, Marra F, Miller D, Brunham RC, Pourbohloul B
DOI: 10.1086/588140
PubMed: 18513154
06/2008

Perceptions of sexual partner safety.
Masaro CL, Dahinten VS, Johnson J, Ogilvie G, Patrick DM
DOI: 10.1097/olq.0b013e3181660c43
PubMed: 18354343
06/2008

Trends in sexual health and risk behaviours among adolescent students in British Columbia.
Saewyc EM, Taylor D, Homma Y, Ogilvie G
PubMed: 23115485
01/2008

Seeking sexual partners on the internet: a marker for risky sexual behaviour in men who have sex with men.
Ogilvie GS, Taylor DL, Trussler T, Marchand R, Gilbert M, Moniruzzaman A, Rekart ML
PubMed: 18615938
2008

Parental intention to have daughters receive the human papillomavirus vaccine.
Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM
DOI: 10.1503/cmaj.071022
PubMed: 18056599
12/2007

Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women.
Ogilvie G, Krajden M, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R, Sherlock C, Taylor D, Rekart M
DOI: 10.1503/cmaj.070013
PubMed: 17724326
08/2007

Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada.
Ogilvie GS, Palepu A, Remple VP, Maan E, Heath K, MacDonald G, Christilaw J, Berkowitz J, Fisher WA, Burdge DR
DOI: 10.1097/01.aids.0000255090.51921.60
PubMed: 17159593
01/2007

Sustained increase in HIV-1 incidence since 2000 among men who have sex with men in British Columbia, Canada.
Lampinen TM, Ogilvie G, Chan K, Miller ML, Cook D, Schechter MT, Hogg RS
DOI: 10.1097/01.qai.0000168182.14523.d4
PubMed: 16186747
10/2005

The impact of syphilis mass treatment one year later: self-reported behaviour change among participants.
Rekart ML, Wong T, Wong E, Hutchinson K, Ogilvie G
DOI: 10.1258/0956462054679179
PubMed: 16105193
08/2005

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.
Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM
DOI: 10.1136/sti.2004.011858
PubMed: 15923286
06/2005

Incorporating a social networking approach to enhance contact tracing in a heterosexual outbreak of syphilis.
Ogilvie G, Knowles L, Wong E, Taylor D, Tigchelaar J, Brunt C, James L, Maginley J, Jones H, Rekart ML
DOI: 10.1136/sti.2003.009019
PubMed: 15800088
04/2005

Report of the 2003 pan-Canadian forum on cervical cancer prevention and control.
Stuart G, Taylor G, Bancej CM, Beaulac J, Colgan T, Franco EL, Kropp RY, Lotocki R, Mai V, McLachlin CM, Onysko J, Martin RE, Elit L, Guijon F, Mann J, Ogilvie G, Romanowski B, Tromp M, Society of Gynecologic Oncologists of Canada, Cervical Cancer Prevention Network of Canada
PubMed: 15560864
11/2004

Access to colposcopy services for high-risk Canadian women: can we do better?
Ogilvie GS, Shaw EA, Lusk SP, Zazulak J, Kaczorowski JA
PubMed: 15490923
2004

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC
DOI: 10.1097/01.inf.0000086400.93257.74
PubMed: 14506368
09/2003

Research

Current Projects
Among other research projects, she is principal investigator for the ASPIRE program, a global health initiative conducting research and providing women-centred, innovative solutions for cervical cancer prevention and reproductive health in sub-Saharan Africa. She also leads HPV FOCAL, which is a randomized trial of over 25,000 women comparing primary screening for cervical cancer, and QUEST, a pragmatic randomized trial defining the effectiveness of reduced dosing of the HPV vaccine.

Grants

Michael Smith Foundation for Health Research Quadrivalent vaccine evaluation study (QUEST) 2012-2024

CIHR Foundation Scheme Integrated global control of HPV related disease and cancer 2015-2022

CIHR A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening 2007-2016

Honours & Awards

Recipient, Distinguished Achievement Award, Applied or Clinical Research, Faculty of Medicine, University of British Columbia

Recipient, Researcher of the Year for BC Chapter of Family Physicians, College of Family Physicians of Canada, July 2014

Canada Research Chair, Tier I “Global control of HPV related disease and cancer” April 2015-April 2022

Research Group Members

Jessica Bow, Research Assistant (on leave)
Robine Donken
Sarai Racey
Clara Rubincam